First-in-man phase 1 trial of ERY-MET

Trial Profile

First-in-man phase 1 trial of ERY-MET

Phase of Trial: Phase I

Latest Information Update: 24 Jun 2018

At a glance

  • Drugs ERY-MET (Primary)
  • Indications Cancer
  • Focus Adverse reactions; First in man
  • Most Recent Events

    • 24 Jun 2018 According to an ERYtech Pharma media release, this study is expected to start in 2018, , with enrollment expected to commence in the first half of 2019.
    • 01 Apr 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top